Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
INDUSTRY
×
zimberelimab
×
Head & Neck
×
Clear all
Filters
3
NCT06727565
2026-03-02
VELOCITY-HNSCC
Gilead Sciences
Phase 2
Active not recruiting
100 enrolled
NCT05891171
2026-02-27
ARC-25
Arcus Biosciences, Inc.
Phase 1
Active not recruiting
40 enrolled
NCT04854499
2025-11-19
ELEVATE HNSCC
Gilead Sciences
Phase 2
Terminated
193 enrolled
27 charts